Log in to your Inderes Free account to see all free content on this page.
Medivir
2.69 SEK
+12.58 %
Less than 1K followers
MVIR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Medivir
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 8.34 | 5.58 | 9.18 | 8.11 | 2.85 | 2.84 | 0.41 |
| Shares | 36.1 | 36.1 | 64.4 | 68.0 | 104.5 | 112.2 | 448.7 |
| Market cap | 301.2 | 201.6 | 591.4 | 551.8 | 297.8 | 318.6 | 183.5 |
| Enterprise value | 166.6 | 131.6 | 370.2 | 426.0 | 128.2 | 256.1 | - |
| EV/S | 19.1 | 9.5 | 14.5 | 96.8 | 16.9 | 73.2 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 1.63 | 1.42 | 2.10 | 2.86 | 1.37 | 2.76 | 0.69 |
| P/S | 34.6 | 14.5 | 23.2 | 125.4 | 39.2 | 91.0 | 21.6 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 62.8 % | 74.1 % | 83.7 % | 82.3 % | 75.7 % | 66.9 % | 86.3 % |
| Gearing ratio | - | - | - | - | - | - | - |
Login required
This content is only available for logged in users